News

Learn more about whether Moderna, Inc. or Protagonist Therapeutics, Inc. is a better investment based on AAII's A+ Investor ...
Learn more about whether Moderna, Inc. or Roivant Sciences Ltd. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Semarion's SemaCyte® technology transforms adherent cell assays, enabling faster, automated workflows that enhance ...
Enveric Biosciences ("Enveric" or the "Company"), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, ...
Merck is a global pharmaceutical giant ... including grid and energy management upgrades in Massachusetts and from the Greater Cambridge Energy Project. The latter is a $1.8 billion investment ...
GSK said it is paying $2.1 billion upfront for Cambridge, Massachusetts-based Affinivax ... That rise came despite the approval of Merck & Co's 15-valent Vaxneuvance in July 2021, which has ...
Merck caspase inhibitors are available from ... Cytokines were measured by ELISA using commercially available kits (Genzyme, Cambridge, MA), as described 19,20. Plates (Nunc Immunoplate Maxisorb ...
Early clinical results suggest the firm's antibodies targeting the Vβ T-cell receptor could induce strong and durable responses in cancer patients.
The Merck layoffs primarily impact its diabetes group in China ... Thermo Fisher Scientific will lay off 160 employees across locations in Lexington, Plainville and Cambridge, MA between January 6, ...
T OFFICIALS SAY T Two pedestrians were injured Thursday when they were hit by an MBTA RIDE vehicle in Cambridge, Massachusetts, according to Transit police. Police responded to a crash involving ...